Research within the DM-CRL focuses on improving long term life outcomes, by developing improved approaches to:
- Diagnosis
- Behavioral and medical treatments
- Quality improvement research
- Developmental trajectories
- Response to treatment
- Biomarkers, including electroencephalogram (EEG), functional magnetic resonance imaging (fMRI), blood, and genetic biomarkers
Our research is focused on neurodevelopmental disorders (NDDs) including, but not limited to:
- Attention Deficit Hyperactivity Disorder (ADHD)
- Autism Spectrum Disorder (ASD)
- Down syndrome (DS)
- Fragile X Syndrome
Internal and external collaborations further expand our reach in the areas of genetics and genomics research, clinical translational research, and treatment studies. Central to this are our national and international partnerships, including those conducted with other Developmental-Behavioral Pediatric centers and our internal partnerships including with the Autism Spectrum Center and Translational Neuroscience Center, Brain, Mind, & Behavior Center. Ultimately, we aim to learn from every patient we see, so that we can provide better care to the patients we see in the future.